
Sign up to save your podcasts
Or


David Gattas gives an update on today's go-to anti-coagulant for renal replacement therapy.
David is an ANZICS CTG power player, with a growing list of publications and was involved in the RENAL and POST-RENAL studies.
This was recorded live at an ICN NSW / ANZICS meeting in September 2014.
By Oliver Flower4.6
2727 ratings
David Gattas gives an update on today's go-to anti-coagulant for renal replacement therapy.
David is an ANZICS CTG power player, with a growing list of publications and was involved in the RENAL and POST-RENAL studies.
This was recorded live at an ICN NSW / ANZICS meeting in September 2014.

1,866 Listeners

541 Listeners

276 Listeners

496 Listeners

100 Listeners

38,379 Listeners

112,574 Listeners

249 Listeners

11 Listeners

109 Listeners

1 Listeners

10,905 Listeners

234 Listeners

42 Listeners